October 7, 2024Open Access

Supplementary Figure 10 from Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer

Key Points

Key points are not available for this paper at this time.

Abstract

Supplemental Figure 10 shows the comparison of DNA based alterations in TP53 and other cell cycle regulation genes compared to "p53-associated" signature from Troester et al. (TP53 score), as well as the association between RFS with TP53 Mutation (DNA) & p53 RNA signature.

Read Full Paperexternally

KI fragen

Bookmark

View Full Paper

Cite This Study

Damrauer et al. (Mon,) studied this question.

synapsesocial.com/papers/68e55b6ce2b3180350ef948b https://doi.org/https://doi.org/10.1158/1078-0432.27183518

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 9 from Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer2024
2Supplementary Figure 11 from Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer2024
3Supplementary Figure 1 from Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer2024
4Supplementary Figure 2 from Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer2024
5Supplementary Figure 5 from Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer2024

KI fragen

Bookmark

View Full Paper